Literature DB >> 24028972

Over-expression of fibroblast activation protein alpha increases tumor growth in xenografts of ovarian cancer cells.

Lijuan Yang1, Li Ma, Dongmei Lai.   

Abstract

Fibroblast activation protein alpha (FAPα) is a 95-kDa serine protease of post-prolyl peptidase family on cell surface. FAPα is widely expressed in tumor microenvironment. The wide spread association of FAPα expression with cancer suggests that it has important functions in the disease. However, the nature of FAPα's roles in cancer cell activity is not well-determined. It has been showed that FAPα silencing in SKOV3 cells induces ovarian tumors but significantly reduces tumor growth in a xenograft mouse model. To further determine the role of FAPα in epithelial ovarian cancer cells, SKOV3-FAPα and HO8910-FAPα cell lines, which over-expressed FAPα stably, were constructed and then their biological behaviors were investigated. It was found that FAPα promoted ovarian cancer cell proliferation, drug resistance, invasiveness, and migration in vitro. Immunochemistry assay showed that FAPα significantly facilitated tumor growth in xenograft tumor tissues. These results suggested that FAPα might directly promote tumor growth and invasiveness in ovarian cancer cells.

Entities:  

Keywords:  fapα; fibroblast activation protein; ovarian cancer; tumor stroma

Mesh:

Substances:

Year:  2013        PMID: 24028972     DOI: 10.1093/abbs/gmt095

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  8 in total

1.  [Construction of a eukaryotic expression vector of fibroblast activation protein and establishment of its stable over-expression in the oral squamous cell carcinoma].

Authors:  Zhao Meng; Shao Tingru; Huang Jiaxin; Chen Yuechuan; Lv Xiaozhi
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2017-10-01

2.  Expression levels of seprase/FAPα and DPPIV/CD26 in epithelial ovarian carcinoma.

Authors:  Mengzhen Zhang; Liwei Xu; Xiaoling Wang; Beibei Sun; Juan Ding
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

Review 3.  The role of fibroblast activation protein in health and malignancy.

Authors:  Allison A Fitzgerald; Louis M Weiner
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations.

Authors:  M M Koczorowska; S Tholen; F Bucher; L Lutz; J N Kizhakkedathu; O De Wever; U F Wellner; M L Biniossek; A Stahl; S Lassmann; O Schilling
Journal:  Mol Oncol       Date:  2015-08-11       Impact factor: 6.603

5.  Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low-dose fraction radiation.

Authors:  Lili Zhao; Shihai Liu; Donghai Liang; Tao Jiang; Xiaoyan Yan; Shengnan Zhao; Yuanwei Liu; Wei Zhao; Hongsheng Yu
Journal:  Cancer Med       Date:  2019-04-02       Impact factor: 4.452

6.  FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer.

Authors:  Li-Na Yu; Zhen Liu; Yan Tian; Pei-Pei Zhao; Xing Hua
Journal:  Front Oncol       Date:  2019-12-17       Impact factor: 6.244

7.  Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways.

Authors:  Jun Jia; Tracey A Martin; Lin Ye; Lin Meng; Nan Xia; Wen G Jiang; Xiaodong Zhang
Journal:  Int J Mol Med       Date:  2017-10-27       Impact factor: 4.101

8.  Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging.

Authors:  Kongzhen Hu; Li Li; Yong Huang; Shimin Ye; Jiawei Zhong; Qingsong Yan; Yuhua Zhong; Lilan Fu; Pengju Feng; Hongsheng Li
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.